About
Cepheid AB is a global leader in molecular diagnostics, based in Solna, Stockholm, Sweden. Founded in 1996, the company focuses on simplifying complex diagnostic processes through its innovative PCR (polymerase chain reaction) technology. With a workforce of approximately 200-500 employees, Cepheid is dedicated to improving healthcare by providing fast, accurate, and flexible diagnostic solutions. The core product of Cepheid is the GeneXpert® system, a fully automated molecular diagnostic platform that performs rapid PCR testing. This system supports a wide range of tests for infectious diseases, oncology diagnostics, women's health, and emerging infectious diseases. Cepheid's solutions are designed for various healthcare settings, ensuring quick and reliable results that enhance patient outcomes. Cepheid serves a diverse global customer base, including hospitals, clinical laboratories, and public health organizations. The company is committed to global public health through initiatives like its Global Access Program, which aims to make high-quality diagnostic tests accessible worldwide.
Technologies
Keywords
Company Information
-
Employees 470
-
Annual Revenue $538576000
Location
2 Roentgenvaegen, Stockholms laen, Sweden, 171 54
